Please login to the form below

Not currently logged in
Email:
Password:

Amitiza

This page shows the latest Amitiza news and features for those working in and with pharma, biotech and healthcare.

Lilly’s Efient and Sucampo's Amitiza win NICE backing

Lilly’s Efient and Sucampo's Amitiza win NICE backing

Lilly’ s Efient and Sucampo's Amitiza win NICE backing. Blood clot and constipation drugs recommended for NHS use. ... The Amitiza recommendation follows earlier draft guidance published in June that determined the drug was a cost effective treatment

Latest news

  • NICE backs constipation treatment NICE backs constipation treatment

    NICE backs constipation treatment. Sucampo’ s Amitiza set for NHS use in England and Wales. ... Sucampo's constipation treatment Amitiza (lubiprostone) should be available on the NHS, according to new healthcare guidance.

  • NICE backs constipation treatment NICE backs constipation treatment

    NICE backs constipation treatment. Sucampo’ s Amitiza set for NHS use in England and Wales. ... Sucampo's constipation treatment Amitiza (lubiprostone) should be available on the NHS, according to new healthcare guidance.

  • AZ drug for opioid constipation starts FDA review AZ drug for opioid constipation starts FDA review

    AZ drug for opioid constipation starts FDA review. Naloxegol on course to compete with Takeda’ s Amitiza. ... Sucampo reported Amitiza sales of a little over $80m in 2012 but that product is also tipped to reach $200m.

  • Sucampo-Takeda to file for US approval of Amitiza as OBD treatment

    It is estimated that 4.5m patients in the US suffer from OBD, so extending Amitiza's indications to include this use could dramatically increase sales. ... added. Sucampo is in the final stages of an arbitration process seeking to revise the terms of its

  • An unexpected turn

    Amitiza (Takeda Pharmaceuticals). Irritable Bowel Syndrome. US. Mycophenolate mofetil (Cellcept; Roche) is an immunosupressant commonly used for treating and preventing transplant rejection.

More from news
Approximately 3 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SpotMe

SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics